首页 正文

Frontline therapy for multiple myeloma: a concise review of the evidence based on randomized clinical trials

{{output}}
The past decade has seen significant progress in the development of new and effective therapies for multiple myeloma. Stem cell transplantation and the introduction of novel agents, such as thalidomide, lenalidomide, and bortezomib, have significantly improved... ...